Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-08-28 | Jennifer Buell, Ph.D., Director, joined us on July 18, 2020, filling the open board seat created when our Board approved the increase of the size of our Board from five to six directors. ... Dr. Buell brings over 20 years of biopharmaceutical R&D experience. ... The Nominating and Corporate Governance Committee consists of Joshua Silverman (Chair), Brian Corvese and Jennifer Buell, Ph.D. ... The Science Committee consists of Jennifer Buell, Ph.D. (Chair), Garo H. Armen, Ph.D. and Robert B. Stein, MD, Ph.D. ... During fiscal year 2019 we did not compensate directors who were not employees of the Company. |
| 2021-09-08 | Jennifer Buell, Ph.D., Director, joined us on July 18, 2020 ... Dr. Buell serves as the President and Chief Operating Officer of Agenus Inc. ... The Audit Committee consists of Brian Corvese (Chairperson), Khalil Barrage, and Jennifer Bueull, PhD. ... The Science Committee consists of Jennifer Buell, Ph.D., Garo H. Armen, Ph.D. and Robert B. Stein, MD, Ph.D. (Chair). ... The Clinical and Regulatory Committee consists of Jennifer Buell, Ph.D. (Chair), Garo H. Armen, Ph.D. and Robert B. Stein, MD, Ph.D. ... During fiscal year 2020 we did not compensate directors who were not employees of the Company. |
Data sourced from SEC filings. Last updated: 2026-03-05